文献速递脑血管病

≥90岁大血管闭塞卒中患者血管内治疗结局

Outcomes of Large Vessel Occlusion Stroke in Patients Aged ≥90 Years.
PubMed 文献 · Stroke · 2021-03-01

基于日本全国性前瞻性多中心登记,纳入150例年龄≥90岁、颈内动脉或大脑中动脉M1段闭塞的急性缺血性卒中患者,比较血管内治疗与药物治疗的结局。血管内治疗组3个月良好结局比例为28.6%,药物治疗组为6.9%,血管内治疗与良好结局独立相关(调整OR 8.44,95%CI 1.88-37.97),症状性颅内出血率组间无显著差异。

要点

  • ≥90岁大血管闭塞患者接受血管内治疗者3个月良好结局比例高于药物治疗者。
  • 血管内治疗与良好结局独立相关,调整OR为8.44(95%CI 1.88-37.97)。
  • 血管内治疗组症状性颅内出血率为0.0%,药物治疗组为3.9%,差异无统计学意义。

核心结论

  • 在≥90岁大血管闭塞卒中患者中,血管内治疗组功能结局优于药物治疗组,且未增加症状性颅内出血。
  • 不应仅根据年龄决定不进行血管内治疗,需结合合适的患者筛选。

研究设计与样本

  • 日本全国性前瞻性多中心登记研究,从2420例急性缺血性卒中大血管闭塞患者中纳入150例年龄≥90岁、颈内动脉或大脑中动脉M1段闭塞者。
  • 比较血管内治疗(49例,32.7%)与药物治疗的结局,采用多变量逆概率治疗加权调整组间偏倚。

主要发现

  • 血管内治疗组3个月良好结局(mRS 0-2或恢复至卒中前mRS)比例为28.6%,药物治疗组为6.9%(P<0.01)。
  • 血管内治疗与良好结局相关,调整OR为8.44(95%CI 1.88-37.97)。
  • 症状性颅内出血率血管内治疗组为0.0%,药物治疗组为3.9%(P=0.30)。
  • 血管内治疗组较药物治疗组发病至到院时间更短(P=0.03)、Alberta卒中项目早期CT评分更高(P<0.01)、静脉溶栓比例更高(P<0.01)。

关键数值与推荐

  • 良好结局定义为3个月时改良Rankin量表评分0-2分或恢复至至少卒中前改良Rankin量表评分。
  • 安全性结局为发病后72小时内症状性颅内出血。

临床怎么用

  • 对于≥90岁颈内动脉或大脑中动脉M1段闭塞的急性缺血性卒中患者,经合适筛选后可考虑血管内治疗。
  • 不应仅因年龄≥90岁而放弃血管内治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Outcomes in patients ≥90 years of age with stroke due to large vessel occlusion were compared between endovascular therapy (EVT) and medical management. METHODS: Of 2420 acute ischemic stroke patients with large vessel occlusion in a prospective, multicenter, nationwide registry in Japan, patients aged ≥90 years with occlusion of the internal carotid artery or M1 segment of the middle cerebral artery were included. The primary effectiveness outcome was a favorable outcome at 3 months, defined as achieving a modified Rankin Scale score of 0 to 2 or return to at least the prestroke modified Rankin Scale score at 3 months. Safety outcomes included symptomatic intracranial hemorrhage within 72 hours after onset. Intergroup biases were adjusted by multivariable adjustment with inverse probability of treatment weighting. RESULTS: A total of 150 patients (median age, 92 [interquartile range, 90-94] years; median prestroke modified Rankin Scale score, 2 [interquartile range, 0-4]) were analyzed. EVT was performed in 49 patients (32.7%; mechanical thrombectomy, n=43). The EVT group showed shorter time from onset to hospital arrival (P=0.03), higher Alberta Stroke Program Early CT Score (P<0.01), and a higher rate of treatment with intravenous thrombolysis (P<0.01) than the medical management group. The favorable outcome was seen in 28.6% of the EVT group and 6.9% of the medical management group (P<0.01). EVT was associated with the favorable outcome (adjusted odds ratio, 8.44 [95% CI, 1.88-37.97]). Rates of symptomatic intracranial hemorrhage were similar between the EVT group (0.0%) and the medical management group (3.9%; P=0.30). CONCLUSIONS: Patients who underwent EVT showed better functional outcomes than those with medical management without increased symptomatic intracranial hemorrhages. Given proper patient selection, withholding EVT solely on the basis of the age of patients may not offer the best chance of good outcome. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02419794.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Fujita K, Tanaka K, Yamagami H, et al. Outcomes of Large Vessel Occlusion Stroke in Patients Aged ≥90 Years. Stroke. 2021. PMID: 33641385. doi:10.1161/STROKEAHA.120.031386

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。